Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-15

Clinical Trial Update: Meropenem and Ciprofloxacin Dosing in Septic Shock

View source ↗

Summary

This document provides an update on dosing of meropenem and ciprofloxacin for septic shock; no status or results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)
  • Meropenem (Meropenem)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Septic Shock | Status: UNKNOWN